Subfascial Transaxillary Breast Augmentation: Critical Evaluation of a 25-Year Review of 1015 Consecutive Cases.

Plastic and reconstructive surgery 2025 Vol.155(3) p. 462-476

Munhoz AM, de Azevedo Marques Neto A

관련 도메인

Abstract

[BACKGROUND] Subfascial (SF) pocket breast augmentation (BA) has gained popularity, whereas the transaxillary approach (TAA) offers the benefit of an inconspicuous scar. Previous reports on both techniques involved limited follow-up/samples, and few clinical studies specifically address surgical technique and outcomes following primary and secondary BA. The purpose of this study was to assess outcomes from the SF TAA technique in a large series of patients who underwent primary and secondary BA.

[METHODS] A retrospective cohort of patients who underwent BA between 1999 and 2024 was identified. The primary outcome was occurrence of incision and implant/pocket complications. Regression logistic analysis evaluated risk factors including age, body mass index, smoking, implant surface/volume, and fat grafting.

[RESULTS] The cohort contained 1015 patients (mean age, 28.5 ± 7.3 years), and the average follow-up was 77.6 ± 38.6 months. In primary BA, 212 patients (23.4%) experienced at least 1 complication, most frequently capsular contracture. More complications were seen in secondary BA ( P = 0.016). Multivariate regression identified body mass index less than 18.5 kg/m 2 as a significant risk factor for incision complications, whereas textured surface (OR, 2.70; P < 0.001) and implant volume greater than 350 cc (OR, 2.79; P < 0.001) were risk factors for implant/pocket complications.

[CONCLUSIONS] Despite extensive research on BA procedures, studies on SF TAA procedures are limited and have not analyzed long-term outcomes following primary/reoperative operations. These results demonstrate that SF TAA is a reliable technique, and the data are compatible with other studies using different BA approaches. Knowledge of the axillary and pectoralis fascia anatomy allows surgeons to safely implement the SF TAA technique and minimize risk.

[CLINICAL QUESTION/LEVEL OF EVIDENCE] Therapeutic, III.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 breast augmentation 유방성형술 dict 2
해부 breast 유방 dict 2
기법 subfascial 근막하 평면 dict 2
해부 fat scispacy 1
해부 axillary scispacy 1
합병증 scar scispacy 1
합병증 capsular contracture 피막구축 dict 1
약물 [BACKGROUND] scispacy 1
약물 implant/pocket scispacy 1
약물 [CONCLUSIONS] scispacy 1
질환 TAA → transaxillary approach C0442341
Transaxillary approach
scispacy 1
질환 follow-up/samples scispacy 1
기타 patients scispacy 1
기타 pectoralis fascia scispacy 1

MeSH Terms

Humans; Female; Retrospective Studies; Adult; Breast Implantation; Axilla; Young Adult; Postoperative Complications; Treatment Outcome; Breast Implants; Follow-Up Studies; Risk Factors; Middle Aged

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문